Physician

Adam Christopher Aubuchon, M.D.

According to 2025 Medicare claims, Adam Aubuchon, M.D. (NPI: 1336431451) practices neurology in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is WAKE FOREST HEALTH NETWORK LLC (NPI: 1700918877; TIN: 561935767) and primary practice location at 27103-6983. Aubuchon is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Aubuchon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 252 traditional Medicare patients, billed 2,886 HCPCS/CPT codes, and received $58,152 in Medicare payments. The top billing code was 95911 (Nerve conduction, 9-10 studies). Part D data shows 917 prescription claims across 218 beneficiaries totaling $180,417 in drug costs, led by Ubrelvy (Ubrogepant). 2023 DME data shows 13 claims. Open Payments data shows 6 records totaling $246. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $12,152 to $58,152. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $14,686 and ending at $180,417. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	63	116	$12,152
2017	167	362	$32,110
2018	196	1,127	$35,575
2019	283	2,247	$69,047
2020	159	1,069	$27,760
2021	181	1,055	$46,730
2022	254	4,262	$70,627
2023	248	1,433	$55,615
2024	252	2,886	$58,152

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	103	$14,686
2016	35	139	$32,565
2017	53	347	$23,678
2018	98	415	$23,930
2019	198	948	$193,064
2020	208	764	$262,614
2021	136	478	$125,896
2022	149	481	$45,875
2023	210	764	$121,112
2024	218	917	$180,417

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$64,235
2023	N/R	13	$74,462
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95911	Nerve conduction, 9-10 studies	27	27	$150
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	59	59	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	86	113	$84
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	76	90	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	74	88	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ubrelvy	Ubrogepant	32	850	$41,050
Emgality Pen	Galcanezumab-Gnlm	34	1,020	$24,138
Nurtec Odt	Rimegepant Sulfate	22	660	$23,601
Rivastigmine	Rivastigmine	14	660	$3,848
Gabapentin	Gabapentin	111	7,172	$3,252

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$246	EMD Serono, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Christopher Aubuchon, M.D.?

Tedicare shows public-source Medicare data for Adam Christopher Aubuchon, M.D. (NPI 1336431451), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Christopher Aubuchon, M.D. have ACO affiliation data?

Adam Christopher Aubuchon, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Adam Christopher Aubuchon, M.D.?

Adam Christopher Aubuchon, M.D. is linked to WAKE FOREST HEALTH NETWORK LLC (billing NPI 1700918877) in the available physician profile data.

Does Adam Christopher Aubuchon, M.D. have Open Payments data?

Adam Christopher Aubuchon, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.